Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trendelenburg as a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients: a Pilot Randomized Controlled Trial

NCT05209737 is registered in ClinicalTrials.gov with Negovsky Reanimatology Research Institute as lead sponsor.

NCT NCT05209737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05209737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trendelenburg as a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients: a Pilot Randomized Controlled Trial
Lead sponsor
Negovsky Reanimatology Research Institute
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2022
Completion date
November 20, 2025
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypotension, shock